| DHA | docosahexaenoic acid |
| EPA | eicosapentaenoic acid |
| COX | cyclooxygenase |
| NSCLC | non-small cell lung cancer |
| NSAIDs | non-steroidal anti-inflammatory drugs |
| DCF | diclofenac |
| PUFAs | polyunsaturated fatty acids |
| PGs | prostaglandins |
| CI | combination index |
| GTPase | nucleotide guanosine triphosphate hydrolase |
| NFκB | nuclear factor kappa-light-chain-enhancer of activated B |
| TGF-β | transforming growth factor beta |
| MEK | mitogen-activated protein kinase/extracellular signal-regulated kinase |
| ERK | extracellular signal-regulated kinase |
| PPARs | peroxisome proliferator-activated receptors |
| MAPK | mitogen-activated protein kinase |
| PI3K | phosphoinositide 3-kinase |
| Akt | protein kinase B |
| mTOR | mammalian target of rapamycin |
| JAK | janus kinase |
| STAT | signal transducer and activator of transcription |
| FITC | fluorescein isothiocyanate |
| RIPA | radioimmunoprecipitation assay |
| BCA | bicinchoninic acid assay |
| GADD45A | growth arrest and DNA damage-inducible alpha |
| TNFAIP3 | tumor necrosis factor alpha-induced protein 3 |
| CDC25C | M-phase inducer phosphatase 3 |
| E2F1 | transcription factor |
| PCNA | proliferating cell nuclear antigen |
| CCNA2 | cyclin-A2 |
| CCNB1 | G2/mitotic-specific cyclin-B1 |
| CCNE2 | cyclin E2 |
| HDAC2 | histone deacetylase 2 |
| POLE2 | DNA polymerase epsilon subunit 2 |
| UBE2T | ubiquitin-conjugating enzyme |
| HIST1H3B | histone H3.1 |
| CDKN2C | cyclin-dependent kinase 4 inhibitor C |